However, 4–10 ng/mL PSA levels (also known as the gray area of PSA) cannot accurately distinguish benign prostatic hyperplasia (BPH) from malignancy or predict tumor progression. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.